ACHE and Alzheimer disease: In 2014, Huang et al. reported that bajijiasu ameliorates Aβ-induced cognitive dysfunction partly through increased ACh levels and decreased AChE levels in the hippocampus at 25 days after Aβ25–35-induced AD [23].